Shinichi Koizumi
Directeur/Membre du Conseil chez TSUBOTA LABORATORY INCORPORATED
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kazuo Tsubota | M | 69 | 12 ans | |
Shintaro Yamada | M | 51 | 12 ans | |
Akihiro Furuta | M | 64 |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
Shinichiro Kondo | M | 55 | 9 ans | |
Takanari Shimizu | M | - | - | |
Andrew M. Saidel | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
Masami Nakane | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
Hironari Hatsuzawa | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
Daisuke Nishii | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
Tatsuya Asai | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Pailin Chuchottaworn | M | 67 |
Tokyo Institute of Technology
| 4 ans |
Tadashi Miyashita | M | 63 |
Tokyo Institute of Technology
| 6 ans |
Koichiro Ikudome | M | - |
Tokyo Institute of Technology
| 1 ans |
Bin Cheng | M | 61 |
Tokyo Institute of Technology
| 4 ans |
Yong Xiang Wang | M | 71 |
Tokyo Institute of Technology
| 1 ans |
Noriya Yokota | M | 63 |
Tokyo Institute of Technology
| 4 ans |
Tomoaki Kobayakawa | M | 61 |
Tokyo Institute of Technology
| 4 ans |
Hiroyuki Kumehara | M | 80 |
Tokyo Institute of Technology
| 3 ans |
Hiroshi Tanie | M | - |
Tokyo Institute of Technology
| 4 ans |
Hironori Tateiri | M | - |
Tokyo Institute of Technology
| 4 ans |
Junichi Rekimoto | M | - |
Tokyo Institute of Technology
| 1 ans |
Yosuke Arimoto | M | 61 |
Tokyo Institute of Technology
| 4 ans |
Yasuo Naruke | M | 69 |
Tokyo Institute of Technology
| 3 ans |
Satoshi Ogiso | M | 63 |
Tokyo Institute of Technology
| 4 ans |
Jim Wang | M | 62 |
Tokyo Institute of Technology
| 3 ans |
Setsu Mimura | M | 60 |
Tokyo Institute of Technology
| 4 ans |
CK Choun | M | - |
Tokyo Institute of Technology
| 5 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Japon | 27 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Shinichi Koizumi
- Réseau Personnel